Navigation Links


analysis at medicine technology

Dade Behrings (hsCRP) Tests and BNTM Series Analyzers

...nning analyses. The test is based on nephelometric analysis of latex particles coated with CRP monoclonal antibodies, which is much more sensitive than prior manual ELISA testing for CRP levels. Current AHA and CDC guidelines indicate that while this test should not be used as routine screening for the genera...

Monitoring Patient Glucose Levels: New Advances in software make it easier

...cose values are automatically downloaded daily for analysis and can be sent to a secure web site online. The physician can log onto the secure web site to view a graph of daily glucose levels for patients, read a summary of relevant statistics for the sensor and calibration readings, and look at a combined mo...

Digital vs. Analog Mammography

... with patient information such as risk probability analysis or other pertinent personal history data for impro...graphy for all but the thinnest breasts. Another analysis of the comparative performance of 18 digital mammography systems and 38 screen-film mammography syst...

Prothrombin Time Comes in Small (CLIA-Waived) Packages

...or health care professionals to enable on-the-spot analysis of coagulation levels during mobile emergency treatment, in hospital and in general practice. The device employs electromagnetic field kinetics to determine PT. A single drop (10 l) of capillary or venous whole blood is applied to a test strip contai...

Lab Automation Networks Proliferating

...integrate with specific Olympus analyzers to yield analysis of from 2,400 to 4,266 tests per hour. Another closed system design comes from Bayer HealthCare Diagnostic Division, Tarrytown, N.Y., a unit of the German firm Bayer AG, in the form of its ADVIA LabCell Modular Automation System. This system provides...

Genetic Analysis Systems Enter the Clinical Mainstream

...estricted to large specialty laboratories, genetic analysis is entering the clinical mainstream. Smaller, simp...signed for a wide range of sequencing and fragment analysis applications and suitable for research, clinical, or forensic labs. This system does not require gel...

New Point-of-Care Methods to Measure Coronary and Cerebrovascular Risk

...roke. This risk was similar even when statistical analysis controlled for the vascular risk factors mentioned...ls. The correlation held up even when statistical analysis controlled for other risk factors. The PREVU(x) test requires only two drops of solution placed on t...

New Quality Control Systems for Every Laboratory Application

...ser support program, assisting customers with data analysis to track the performance of their assays. With the...d up by good customer service and appropriate data analysis programs from the vendor. Fortunately, new QC materials are keeping pace with the demands of laborat...

Hematology Analyzers Simple, Sophisticated Technology Serving All Patients

...ophisticated analyzers, dual angle optical scatter analysis combines optical signals from two independent ligh... programs ranging from basic QC data retrieval and analysis to internet-based real-time data sharing systems. Beyond improving user safety and convenience, thes...

Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing

...e the first system was invented in 1957, blood gas analysis has revolutionized clinical medicine and patient care. During the 1960s, blood gas analysis became almost universally available, and blood gases were considered "the most important laboratory ...

Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing

...rements in some instances. Based on solid clinical analysis and a few simple laboratory tools, such as CBC and... fluctuations during fever. This allows a dynamic analysis of the infection progression and can lead to more accurate and prompt administration of antibiotic t...

Optimizing Quality Control Data Management

...quality control data review Provides advanced data analysis charts and reports Enables the consolidation of qu...lso use Unity Real Times Bench Review for run-time analysis and Supervisor Review for periodic supervisory data analysis. Bench and Supervisor Review Unity R...

Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial

...rsparticipating in the trial and by an independent analysis ofpatient scans; time to tumour progression (a mea...One patient in the ASA404 arm wasexcluded from the analysis of survival and one patient in thechemotherapy-alone arm was excluded from the independent analyseso...

Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

...arin40 mg). Also presented at ISTH was a pooled analysis of major VTE andVTE-related mortality after primar...MOBILIZE(TM) and RE-NOVATE studies).(ii) Thepooled analysis concluded that dabigatran etexilate wasnon-inferior to enoxaparin in the prevention of major VTE and...

Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy

...to discussing theseresults and our planned interim analysis of the PIX301 (EXTEND)pivotal trial with the FDA. ...proximately half of study participants. Theinterim analysis was conducted after approximately 60 patientscompleted at least four cycles of therapy to determine ...

Halozyme Therapeutics' Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society

...y completed modeledpopulation pharmacokinetic (PK) analysis used to estimate theeffect of steady state co-admi...n the study. -- The modeled population PK analysis estimated a 59% maximal increase in the relative SC bioavailability of adalimumab at steady st...

Protox Announces Positive Clinical Data from Prostate Cancer Study

... that will include top-linePSA data with expanded analysis of PSADT and PSAV will beavailable for release in October. Plans are underway tocommence a Phase 2 study before the end of the year. Conference call Protox will host a conference call and live webcast today at12:00 p.m. E.T. to discuss th...

Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer

...trand breaks such as those caused bycisplatin. The analysis of ERCC-1 levels in this study wasconducted by Res...hnologies. RGI's technologies enableextraction and analysis of genetic information from genes derivedfrom tumor samples stored as formalin-fixed and paraffin em...

Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

...CDAD and the timing of suchdiscussions; additional analysis of the data from the first Phase 3study; the results of the second Phase 3 study and whether suchresults are consistent with this data; the timing of the secondPhase 3 study; and the risks and uncertainties described in reportsfiled by Genzyme with t...

New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV

...y 05, 2007 /PRNewswire/ -- Results fromthe primary analysis of a randomized, controlled, open-label, Phase3 st...versity of Illinois, Chicago. The 48-week primary analysis from the TITAN study providesadditional information regarding efficacy and safety of PREZISTA/rin co...

Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea

...thus better meet patients' requirements." Further analysis of the data is ongoing. About Cosmo Pharmaceuticals Cosmo is a speciality pharma company that aims to become aglobal leader in optimised therapies for certain gastrointestinaldiseases. The com­pany's proprietary clinical developmentpipeline spe...

Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients

...factor receptor– but it is the most detailed analysis todate. The study, published in the July 1 issu... EGFR inhibition in skintissue, Wacker said. The analysis looked at two placebo-controlled, double-blind,randomized, Phase III clinical trials testing Tarceva...

Researchers Discover Method for Identifying How Cancer Evades the Immune System

...ral defenses. Intime, the researchers believe such analysis could become a standardpractice in cancer diagnosis and treatment. “The implication is that once you know the mechanism by whichtumors evade the immune system, you can match that tumor toavailable therapies,” said senior author Alan L.E...

Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)

...iated during the first quarter of 2007. Theinterim analysis indicates: - the desired pharmacodynamic effect was observed as anticipatedindicating the high potency of ALX-0081 - ALX-0081 was well tolerated and showed no serious adverseeffects or dose limiting toxicity The final results are anticipated to ...

Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial

...onsiderations For Non-Inferiority For statistical analysis pursuant to the Company's protocol andconsistent w...approved as a treatment for CAP, and datafrom this analysis have not been reviewed by the FDA. Update to Trial CL-05 Timeline The Company also updated the pro...

Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

... paper's authors collate recent developments inthe analysis of the role of COMT genotypes and their involvement incognitive deficits in schizophrenia and bipolar disorder. The papersupports the view that there is potential to use COMT inhibitors inameliorating their cognitive deficits via an effect on prefron...

Alkermes Announces Positive Results from Phase 1/2 Clinical Study of ALKS 29

...comes for patients. We look forward to thecomplete analysis of these data, as we believe insights from thisstudy could help pave the way for the development of ALKS 29 andother proprietary oral compounds for the treatment of alcoholdependence." In the phase 1/2 study, patients treated with ALKS 29demonstra...

European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGene's Cancer-Killing Virus in Press Conference

...dpositive safety and efficacy data from an interim analysis of thisstudy. The poster presented at the ESMO conference shows efficacydata in a case study for the first time. Dr. Ulrich Delvos, Chief Operating Officer of MediGene,comments. "We are delighted and proud that the European Society forMedical Onco...

Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients

... efficacy inuntreated MM patients. The preliminary analysis included 15evaluable patients, who received VELCADE at 1.0 mg/m(2) or 1.3mg/m(2) on days 1, 4, 8 and 11 of a 21- day schedule. Patients alsoreceived lenalidomide at 15, 20 or 25 mg on days 1 through 14 anddexamethasone at 40 mg corresponding with the...

Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types

...7 /PRNewswire-FirstCall/ -- Resultsfrom an interim analysis of a Phase III study show thatCERVARIX(R), the Gla...ity of precancerous lesions included inthe primary analysis had multiple cancer-causing virus typesdetected, making it difficult to clearly determine which viru...

CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP

...rol) in subjects with active RA.In the preliminary analysis of this trial, CRx-150 demonstratedstatistically significant effects on DAS28 and pain, a trend onACR20 and no effect on CRP. -0- Measure Regimen ITT Population PP Population------------------------------------------------------------DAS...

Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis

...ing that 50% of the patients in theblinded interim analysis should be on SinuNase, and 50% on placebocontrol. "The data reported is very encouraging," said Dr. Frank E.O'Donnell Jr., Chairman and Chief Executive Officer of AccentiaBiopharmaceuticals. "While we cannot determine which patients arereceiving Si...

A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients

... in Transition's press release on March 5th, 2007, analysis ofefficacy parameters was performed on type 2 diabetes patients withHbA1c levels of equal to or greater than 7% prior to treatment. In the E1-I.N.T.(TM) treated group of patients, the mean HbA1clevel was reduced by 0.94% to 1.21% vs. baseline levels...

Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company

...liminary findings. TheLFA looks forward to further analysis of the data and will reportthis information as soon as it becomes available. About the LFA: The Lupus Foundation of America is the nation'sleading nonprofit voluntary health organization dedicated tofinding the causes and cure for lupus. The LFA and...

Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis

...; the FDA may determine that the design andplanned analysis of our clinical trials do not adequately addressthe trial objectives in support of our regulatory submission;future sales of CellCept may be less than expected; our futureoperating results are uncertain and likely to fluctuate; we may notbe able to d...

Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer

...maryendpoint, the FDA may require additional data, analysis or studiesbefore the NDA is approved by the FDA; the outcome of anydiscussions with the FDA; the initiation, timing, design,enrollment and cost of clinical trials; unexpected delays inclinical trials and preparation of materials for submission to the...

ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model

...eloss as a result of the myeloma. Histomorphometry analysis revealedthat mice treated with ACE-011 had normal bone formationparameters, while untreated mice had reduced bone formation andincreased bone resorption. Furthermore, ACE-011 preserved thenumber of osteoblasts, the cells responsible for forming new b...

An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes

... monotherapy. The results of the betacell modeling analysis showed that the addition of JANUVIA tometformin re...harmacokinetics ofsitagliptin based on a composite analysis of Phase I pharmacokineticdata and on a population pharmacokinetic analysis of Phase I and PhaseII d...

New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir

...he new data presented at ADA were from a six-month analysis of5,604 Type 2 diabetes patients, in a mainly primary care settings,and predominantly treated with Levemir® once-daily, as anadd-on therapy to any other glucose-lowering regimens, or asreplacement of a previous basal insulin. Patients wererandom...

Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke

..., comparedwith placebo. The results are from a new analysis of the landmarkStroke Prevention by Aggressive Red...klin University ofMedicine & Science. "In this analysis of patients with type 2diabetes with no known coronary heart disease, we found Lipitor tobe effectiv...

Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes

...f 8.3), weresubjected to a pre-specified secondary analysis focused onCycloset(TM)'s ability to reduce HbA1c after 24 weeks of therapy.Those receiving Cycloset(TM) and completing 24 weeks of therapy(121 subjects) experienced a mean HbA1c reduction of 0.69 (P =0.0002) compared to respective placebo (71 subject...

Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes

...is a patient's startinglevel of A1C. In a subgroup analysis of patients grouped byseverity of starting baselin...Merck expects FDA action by mid-October. A pooled analysis of 5,141 patients showed overall incidence ofadverse experiences, incidence of serious adverse exper...

New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes

...ould be affected by,among other things, additional analysis of clinical data; newclinical data; unexpected clinical trial results; unexpectedregulatory actions or delays in government regulation generally;the company's ability to obtain or maintain patent or otherproprietary intellectual property protection; ...

New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir

...he new data presented at ADA were from a six-month analysis of5,604 type 2 diabetes patients, in a mainly primary care settings,and predominantly treated with Levemir(R) once-daily, as an add-ontherapy to any other glucose- lowering regimens, or as replacementof a previous basal insulin. Patients were randomi...

Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal

...igham and Women's Hospital in Boston. The interim analysis compared pregnancy rates and patientpreferences am...ive officer of ColumbiaLaboratories. "The interim analysis shows women receiving CRINONE 8% reportedfewer side effects and greater overall satisfaction versus ...

New Report 'Looking at Chiral Technologies' Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals

...hiral Pool, Resolution, Biocatalysts, orasymmetric analysis creates the required compounds. The majority ofdevelopment activity is routed through fine chemical companieswhich are additionally trying to upgrade their capabilities inorder to provide to the entire portfolio of pharmaceutical drugsfor application...

GenoLogics Announces Bioinformatics Partnership with Illumina

...blished by Illumina to advancedata integration and analysis among the life science community. GenoLogics will...ffering Geneus with integrations to theirBeadArray analysis software, BeadStudio, which will enable ourcustomers with gene expression and genotyping application...

MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions

...s and reduced glomerular filtration rate: an analysis from PROactive; Poster 0671-P presented on S... 6:15-7:30 p.m. -- Long-term cost-effectiveness analysis on ACTOS for the USA from PROactive; Poster 1209-P presented on Sunday, June 24, from 12-2 p.m...

Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis

...shown to be safe and effective. The "per-protocol" analysis ofTovaxin therapy achieved a 92% reduction in annualized relapse rate(ARR) in subjects who received two treatment doses of 30 - 45 x10(6) attenuated T-cells eight weeks apart and were monitored foran additional 44 weeks. Subjects in the extension stu...

New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy

...ompared with those in the placebogroup. "Recent analysis of the data from the WHI study haveconsistently clarified the initial data, to show that in the newlydiagnosed population of menopausal women, estrogen therapy does notincrease cardiovascular disease and that there actually is astatistically signific...

Cethromycin Achieves Primary Endpoint in Pivotal Phase 3 Pneumonia Clinical Trial

...approved as a treatment for CAP, and datafrom this analysis have not been reviewed by the FDA. No furtherdetails of the clinical study will be available until all dataanalyses are complete and results are presented in a public,scientific forum. Program Design The Phase 3 CAP clinical trial program is compri...

Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer

...ived WBRTalone, according to a stratified log rank analysis of overallsurvival (8.5 months vs. 7.5 months; haz...arfollowing completion of a pre- specified interim analysis ofresponse data after 35 patients have completed at least one cycleof treatment with PDX." About PD...

Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan

...G,Inc. reported positive results following interim analysis of datafrom the first 41 subjects to complete a Ph... Gene Therapy in Japan AnGes conducted an interim analysis of the PIII data using HGFGene (AMG 0001) for Critical Limb Ischemia (CLI) in Japan, and ispleased t...

New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus

...gions inanimal and human strains of flu virus. The analysis identified sixhighly conserved regions within several proteins that are capableof triggering an immune response. These six regions were then chemically synthesised as smallprotein fragments called peptides. The resulting preparation,FLU-v, was used ...

First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex

...hing fromtamoxifen to anastrozole (ArimidexTM). An analysis of the‘Arimidex’-‘Nolvadex&rsquo...ent for early-stagebreast cancer: long-term safety analysis of the ATAC trial. LancetOncology 2006; 7 (8): 633-643 [v] Saphner T, Tormey DC and Gray R. Annual ...

Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for Heart Failure

...n.Echocardiographic and magnetic resonance imaging analysis showedthat the animals transplanted with GRNCM1 cells had improved(smaller) end-left ventricular systolic and diastolic diameters,increased fractional shortening, improved infarct wall thickeningand increased ejection fraction compared to control ani...

Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate

...and uncertainties include,among others: additional analysis of the data comparing the powderform of Renvela™ to Renagel®; the results of otherstudies and whether such results are consistent with this data; theactual efficacy and safety of Renvela™ for chronic kidneydisease; the outcome of disc...

Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate

...and uncertainties include,among others: additional analysis of the data comparing the powderform of Renvela(TM) to Renagel(R); the results of other studies andwhether such results are consistent with this data; the actualefficacy and safety of Renvela(TM) for chronic kidney disease; theoutcome of discussions ...

New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus

...gions inanimal and human strains of flu virus. The analysis identified sixhighly conserved regions within several proteins that are capableof triggering an immune response. These six regions were then chemically synthesised as smallprotein fragments called peptides. The resulting preparation,FLU-v, was used ...

Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen

...tching fromtamoxifen to anastrozole (Arimidex). An analysis of the'Arimidex'-'Nolvadex 95' (ARNO 95) study, published online in TheJournal of Clinical Oncology, confirms that postmenopausal womenwho have been taking tamoxifen as part of their treatment for earlybreast cancer for two years can significantly re...
Other Contentscentriolecentriolecellulosecellulosecellulosecellulosecellulosecellulosecentromerecentromerechemiosmoticcentrosomecentrosomecentrosomesquaresquaresquaresquaresquaresquaresquarechichlorophyllchlorophyllchlorophyll
(Date:5/16/2008)...ncer, nervous system disorders such as Parkinsons ... one thing in common: Both in afflicted tissue and...e changes in important biomolecules. These are cau...torious free radicals that are formed as a by-prod...oteins, nucleic and fatty acids. , Today, reacti...
(Date:5/15/2008)...MBRIDGE, Mass.--As Charles Darwin showed nearly 15... the birds, feeding strategy. A team of MIT mathem...ow some shorebirds use their long, thin beaks to d..., The phalarope, commonly found in western North...between its beak and water droplets to propel bits...
(Date:5/15/2008)...y 15, 2008 (BRONX, NY) Contrary to long-held ass...k of death, according to investigators from the Al...rsity. They reached their conclusion after examini...e sample of adults in the U.S. The Einstein resear...risk of death from cardiovascular disease (CVD) as...
(Date:5/15/2008)...MBRIDGE, Mass.--MIT engineers have improved the po...0 percent through technology that could help these...ind a much broader market, particularly in portabl...k is also considerably less expensive than its con...ntages. , Our goal is to replace traditional fue...
Breaking Biology News(10 mins):Biosensor for measuring stress in cells 2MIT solves gravity-defying bird beak mystery 2MIT solves gravity-defying bird beak mystery 3New study casts further doubt on risk of death from higher salt intake 2MIT creates new material for fuel cells 2MIT creates new material for fuel cells 3FDA Grants Priority Review for Daiichi Sankyo Lilly Drug prasugrel 1407 1FDA Grants Priority Review for Daiichi Sankyo Lilly Drug prasugrel 1407 2FDA Grants Priority Review for Daiichi Sankyo Lilly Drug prasugrel 1407 3By color coding atoms new Cornell electron microscope promises big advance in materials analysis 12434 1By color coding atoms new Cornell electron microscope promises big advance in materials analysis 12434 2By color coding atoms new Cornell electron microscope promises big advance in materials analysis 12434 3UC study 3A New devices less effective in thwarting brain aneurysm recurrence 12430 1UC study 3A New devices less effective in thwarting brain aneurysm recurrence 12430 2Cats Help Shield Owners From Heart Attack 12426 1Cats Help Shield Owners From Heart Attack 12426 2Cats Help Shield Owners From Heart Attack 12426 3
(Date:5/16/2008)...e Vital Services for Frail Seniors and People With...e-USNewswire/ -- Thousands of,homecare workers acr...negger,s proposed cuts to hours of service, wages ...,s most vulnerable workers and the,people they ser... vital,services for seniors and people with disabi...
(Date:5/16/2008)... Urban Health Institute with 10,000 Sensual O Cond... Playboy Mansion Fundraiser, LOS ANGELES, May 16 ...p,and R & B artist J Kwon known best for his hit s... presenting the Urban Health Institute (UHI) with,... $50,000. The donation is,being made to promote th...
(Date:5/16/2008)...determine who would benefit most from chemo after ...HealthDay News) -- A panel of 15 genes may help de...cell lung cancer will experience a recurrence and,...new study shows. , By extension, the same gene... aggressive forms of the cancer who would be able ...
(Date:5/16/2008)...May 16 /PRNewswire-USNewswire/ -- As tropical stor...awaddy delta, survivors of,Cyclone Nargis are vuln...,survivors still need assistance, as exposure to t...ncreasingly dire situation., "The people living i...ver from this disaster and get back on their feet,...
Breaking Medicine News(10 mins):Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Everybody in the Club Scream O! 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 2Health News:Gene Signature May Predict Recurrence of Lung Cancer 3Health News:Myanmar Cyclone Survivors Face New Challenges 2
Other TagsInterventionStillStillStillStillPortionAffectedPermanentOther Tagshay 2traditional 2traditional 3traditional 4traditional 5traditional 6traditional 7traditional 8traditional 9traditional 10driven 2driven 3driven 4driven 5driven 6driven 7symptom 2symptom 3symptom 4symptom 5symptom 6symptom 7symptom 8symptom 9symptom 10producing 2producing 3producing 4producing 5producing 6producing 7producing 8producing 9producing 10progress 2progress 3progress 4progress 5progress 6progress 7progress 8progress 9progress 10former 2former 3former 4former 5former 6former 7former 8